Humimic Biosystems
ActiveHumimic Biosystems provides organ-on-chip models for human-relevant preclinical research and drug testing.
What it does
Humimic Biosystems is a deeptech and lifetech company specializing in organ-on-chip technology to enhance preclinical research and accelerate drug discovery. The company offers a range of microfluidic chips that replicate human organ functions, including models of heart muscle, heart valve, blood-brain barrier, nasal airway, and skeletal muscle. These innovative products provide human-relevant, high-accuracy data that address the limitations of traditional animal testing, reducing risks in human trials and speeding the development of new treatments. By enabling deeper insights into disease mechanisms and minimizing reliance on animal models, Humimic Biosystems supports pharmaceutical companies, researchers, and academic institutions in conducting more predictive and ethical research. The platform is designed for scalability and ongoing collaboration, contributing to advancements in human health and compliance with evolving research standards.
Next to it in Healthcare and bio · organ-on-chip models for drug discovery
- NEXI Biotech IncPlug and Play PnP 2026
NEXI Biotech develops in vitro neurotechnology models for improved neurological drug discovery and translation.
- OMAntler Antler US 2024
go from hypothesis to launching a discovery program in under a week
- BiocartesianY Combinator S24
Converting biology into digital molecular maps
- AnuBioPlug and Play PnP 2026
Reprogramming immunomodulation using AI to cure cancer
- RasynY Combinator S26
Towards a General Intelligence for Chemistry
- WonderTxY Combinator S26
Extrapolative AI to unlock First-in-Class drugs
- elegslabPlug and Play PnP 2026
elegslab accelerates drug discovery with AI-automated C. elegans platforms—a next-generation NAMs solution.
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease